Check out the new Prime/MRx GLP-1 Strategy page - Prime Therapeutics
Check out the new Prime/MRx GLP-1 Strategy page
New resource page offers the latest GLP-1 insights, research and perspectives
After the release of its industry-leading research on GLP-1 drugs for weight loss in July 2023, Prime Therapeutics/Magellan Rx Management (Prime/MRx) continues to shape the narrative on this dynamic trend.
We’ve compiled all of our GLP-1 resources and thought leadership onto a new GLP-1 Strategy page, including our research, podcasts, videos, recent articles and more. Our aim is to highlight our evidence-based approach to GLP-1 drugs, working with our partners to develop individualized strategies that promote clinically appropriate use and consider total cost of care, long-term value, and member health outcomes.
For more, check back for regular updates on our Prime News site.
And to get the latest news and insights from Prime/MRx, sign-up for our twice-a-month newsletter, Prime Post.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.